Who
In numbers
- Trades disclosed
- 127
- Buys
- 0
- Sells
- 23
- Bought
- $0
- Sold
- $1.1M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Mar 2023
- Last trade
- 16 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Oct 2026filed 19 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $19K116 at $165.88 | filing |
| 15 Oct 2026filed 19 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 15 Oct 2026filed 19 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 16 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $20K116 at $175.00 | filing |
| 16 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $20K116 at $175.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —249 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $18K116 at $156.45 | filing |
| 17 Aug 2026filed 18 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $18K116 at $156.45 | filing |
| 15 Aug 2026filed 18 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 16 Jul 2026filed 16 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $19K116 at $163.29 | filing |
| 16 Jul 2026filed 16 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $19K116 at $163.29 | filing |
| 15 Jul 2026filed 16 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —250 at $0.00 | filing |
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026Guardant Health (NASDAQ:GH) Director Sells $19,242.08 in StockGH · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Musa Tariq; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.